United Healthcare updates protocol on acquisition for administration of sodium hyaluronate preparations,
effective April 1, 2010. ORTHOVISC® High Molecular Weight Hyaluronan remains an approved HA product for buy and bill.
Please contact your ORTHOVISC® Representative for more information.
ORTHOVISC® is eligible for reimbursement by Medicare and most managed care plans. Depending upon reimbursement coverage, ORTHOVISC® can be obtained by purchasing directly from DePuy Mitek Customer Service at 1-800-382-4682 or writing an ORTHOVISC® prescription. Insurance policies and coverage for ORTHOVISC® vary patient to patient and plan to plan. It is recommended to check with a specific patient insurance carrier to verify coverage. If you have questions about ORTHOVISC® Medicare or Private Pay Insurance coverage, contact ORTHOVISC®Line, our reimbursement support hotline, at 1-866-633-VISC (8472).
JCode Source: Federal Register/Vol.72, No. 227,pp 66774/Tuesday, November 27, 2007. All Current Procedural Terminology (CPT) five-digit numeric codes, descriptions, numeric modifiers, instructions, guidelines, and other material are Copyright 2007 American Medical Association. All Rights Reserved.
ICD-9 is based on the official version of the World Health Organization's Ninth Revision, International Classification of Diseases.
CPT codes and descriptions only are Copyright 2007 American Medical Association. All Rights Reserved.